BBA
BIIB icon

BLB&B Advisors’s Biogen BIIB Stock Holding History

BLB&B Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-843
Closed -$202K – 254
2021
Q4 		$202K Sell
843
-200
-19% -$51.4K 0.01% 248
2021
Q3 		$295K Buy
1,043
+200
+24% +$65.5K 0.02% 232
2021
Q2 		$292K Sell
843
-1
-0.1% -$303 0.02% 216
2021
Q1 		$236K Sell
844
-215
-20% -$58K 0.02% 228
2020
Q4 		$259K Buy
1,059
+75
+8% +$19.3K 0.02% 231
2020
Q3 		$279K Hold
984
– – 0.03% 205
2020
Q2 		$263K Sell
984
-44
-4% -$13.2K 0.03% 209
2020
Q1 		$325K Hold
1,028
– – 0.04% 191
2019
Q4 		$305K Sell
1,028
-180
-15% -$49.9K 0.03% 225
2019
Q3 		$281K Hold
1,208
– – 0.03% 230
2019
Q2 		$283K Buy
+1,208
New +$279K 0.03% 230
2019
Q1 		– Sell
-1,195
Closed -$360K – 279
2018
Q4 		$360K Sell
1,195
-178
-13% -$56.8K 0.05% 202
2018
Q3 		$485K Buy
1,373
+58
+4% +$20K 0.06% 192
2018
Q2 		$382K Sell
1,315
-50
-4% -$14.1K 0.05% 210
2018
Q1 		$374K Buy
1,365
+95
+7% +$29.5K 0.05% 214
2017
Q4 		$405K Buy
1,270
+65
+5% +$20.9K 0.06% 208
2017
Q3 		$377K Hold
1,205
– – 0.06% 206
2017
Q2 		$327K Hold
1,205
– – 0.05% 211
2017
Q1 		$329K Hold
1,205
– – 0.06% 210
2016
Q4 		$342K Buy
1,205
+355
+42% +$105K 0.06% 215
2016
Q3 		$266K Hold
850
– – 0.05% 237
2016
Q2 		$206K Buy
+850
New +$224K 0.04% 254

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

BLB&B Advisors's BIIB Position: Q1 2022 in Review

BLB&B Advisors sold out of Biogen (BIIB) in Q1 2022, closing a stake of 843 shares — an estimated $202K sold.

BLB&B Advisors first reported a position in BIIB in Q2 2016 and held it in 22 quarters. The position peaked at $485K in Q3 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • BLB&B Advisors reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • BLB&B Advisors sold 843 Biogen shares in Q1 2022, an estimated $202K.
  • BLB&B Advisors first reported a position in Biogen in Q2 2016 and held it in 22 quarters.
  • BLB&B Advisors's Biogen position peaked at $485K in Q3 2018.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on BLB&B Advisors's 13F filing for Q1 2022, filed 20 Apr 2022.